Versigent PLC (VGNT) Stock Forecast
VGNT analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.70 / 5 from 10 analysts
- Price target
- $56.78 average of analyst targets
- Upside to target
- +28.4% from the latest close
- Next earnings
- November 4, 2026 EPS estimate $1.79
- 52-week range
- $26.94 – $50.22
VGNT analyst ratings
10 analystsNumber of analysts at each rating.
VGNT price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
VGNT earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.72 | $1.52 | $1.97 | — | — | 6 |
| Current fiscal year (2026) | $7.29 | $6.93 | $7.89 | — | — | 10 |
| Next fiscal year (2027) | $7.72 | $6.71 | $8.21 | $7.29 | +5.9% | 10 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
VGNT revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.42B | $2.40B | $2.47B | — | 5 |
| Current fiscal year (2026) | $9.52B | $9.49B | $9.60B | +8.0% | 8 |
| Next fiscal year (2027) | $9.83B | $9.69B | $9.96B | +3.2% | 9 |
VGNT EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
VGNT revenue: reported and forecast
VGNT EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.87 | $1.76 | $1.76 | $1.70 | $1.72 | −8.2% | 1 up · 2 down |
| Current fiscal year (2026) | $6.85 | $7.36 | $7.36 | $7.27 | $7.29 | +6.5% | 1 up · 3 down |
| Next fiscal year (2027) | $7.62 | $7.81 | $7.77 | $7.72 | $7.72 | +1.3% | 0 up · 3 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
VGNT earnings surprises
Reported EPS vs the consensus estimate for the last 2 quarters; VGNT beat in 1 of 2.
What analysts expect from VGNT
10 analysts cover Versigent; their consensus rating is strong buy (4.70 on a 1–5 scale, where 5 is a strong buy). The average price target is $56.78, 28.4% above the latest close of $44.22. Analysts expect earnings of $7.29 per share for 2026. For 2027 the average estimate is $7.72 per share on revenue of $9.8 billion. Versigent beat the EPS estimate in 1 of the last 2 quarters.
Related: VGNT income statement, VGNT key metrics, VGNT chart. See the VGNT stock overview for the latest quote and news.
VGNT forecast FAQ
What is Versigent's price target?
The average analyst price target for Versigent is $56.78, 28.4% above the latest close of $44.22.
Is Versigent a buy, hold or sell?
Of 10 analysts covering Versigent, 7 rate it a strong buy, 3 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Versigent's EPS forecast?
Analysts forecast $7.29 per share for 2026 (range $6.93 to $7.89); for 2027 the estimate is $7.72.
What is Versigent's revenue forecast?
The average revenue estimate for 2026 is $9.5 billion, growth of 8.0%; for 2027 it is $9.8 billion.
When does Versigent report earnings?
Versigent is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 before the market opens; the EPS estimate is $1.79.
Does Versigent usually beat earnings estimates?
Versigent reported EPS at or above the analyst estimate in 1 of the last 2 quarters.